Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/185547
Title: Measuring cigarette dependence: A comparison of two scales in two different groups of smokers
Author: Fu Balboa, Marcela
Carnicer Pont, Dolors
Castellano, Yolanda
Ballbè i Gibernau, Montse
Sureda, Xisca
Raich, Antònia
Martínez Sánchez, Jose
Martínez, Cristina
Baena, Antoni
Riccobene, Anna
Enríquez, Marta
Fernández Muñoz, Esteve
Keywords: Hàbit de fumar
Anàlisi de conducta
Smoking
Behavioral assessment
Issue Date: 8-Apr-2022
Publisher: E.U. European Publishing
Abstract: INTRODUCTION The Fagerstrom Test for Cigarette Dependence (FTCD) and the Cigarette Dependence Scale (CDS) are usually used to assess cigarette dependence in clinical-and population-based studies. Our objective was to compare these two scales within groups of smokers from both contexts. METHODS The study was observational with smokers from a representative sample of the adult general population (n=188) and smokers attending a smoking cessation clinic in Barcelona, Spain (n=759). The FTCD and the CDS-5 (short version of 5 items) were used to assess cigarette dependence. We compared the standardized median scores obtained with both scales within each group of smokers by selected variables. To this aim, we re-scaled the scores of both scales to allow their comparison and assess their correlation within both groups. RESULTS The scores obtained with both scales were highly correlated within both groups of smokers (p<0.001), indicating good agreement in the assessment of cigarette dependence. Nevertheless, higher standardized CDS-5 scores were observed more frequently in the population group overall (3.9 vs FTCD score=3.7, p=0.001), among women (4.5 vs 4.2; p<0.001), in the youngest group of smokers (3.9 vs 3.2; p 0.007) and in light smokers (time to the first cigarette >60 min; 1.7 vs 1.1; p<0.001). CONCLUSIONS While the CDS-5 scored higher more frequently in the population group, the FTCD scored higher more frequently in the clinical group. These differences should be considered when designing either clinical-or population -based studies.
Note: Reproducció del document publicat a: https://doi.org/10.18332/tpc/146714
It is part of: Tobacco Prevention & Cessation, 2022, vol. 8, num. 4
URI: http://hdl.handle.net/2445/185547
Related resource: https://doi.org/10.18332/tpc/146714
ISSN: 2459-3087
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
146714-74282.pdf282.66 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons